Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score The Mycophenolate Pregnancy Registry 11/26/2012 OBSERVATIONAL unchanged 5,021.85 0 PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer 11/29/2012 INTERVENTIONAL unchanged 5,018.85 0 The Women's Health Study: From Adolescence to Adulthood 11/30/2012 OBSERVATIONAL unchanged 5,017.85 0 Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL) 12/10/2012 OBSERVATIONAL unchanged 5,007.85 0 Evaluation of IVA (SE Femur Scans) to Identify Incomplete AFFs 12/11/2012 OBSERVATIONAL unchanged 5,006.85 0 Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer 01/11/2013 INTERVENTIONAL unchanged 4,975.85 0 Group Interventions for Breast Cancer Survivors 01/24/2013 INTERVENTIONAL unchanged 4,962.85 0 Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening 02/04/2013 INTERVENTIONAL unchanged 4,951.85 0 Pre Operative Trastuzumab in Operable Breast Cancer 02/07/2013 INTERVENTIONAL unchanged 4,948.85 0 Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma 02/11/2013 OBSERVATIONAL unchanged 4,944.85 0 A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer 02/15/2013 OBSERVATIONAL unchanged 4,940.85 0 OTIS Cimzia Pregnancy Registry 02/22/2013 OBSERVATIONAL unchanged 4,933.85 0 Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis 02/26/2013 INTERVENTIONAL unchanged 4,929.85 0 Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy 03/06/2013 INTERVENTIONAL unchanged 4,921.85 0 Reproductive Health Program in Patients With Cancer 03/07/2013 INTERVENTIONAL unchanged 4,920.85 0 Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study 03/22/2013 OBSERVATIONAL unchanged 4,905.85 0 The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma 03/29/2013 INTERVENTIONAL unchanged 4,898.85 0 The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma 03/29/2013 INTERVENTIONAL unchanged 4,898.85 0 Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors 04/05/2013 INTERVENTIONAL unchanged 4,891.85 0 A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) 04/05/2013 INTERVENTIONAL unchanged 4,891.85 0 Prospective Data Bank Creation to Study Vaginal Conditions 04/11/2013 OBSERVATIONAL unchanged 4,885.85 0 Breast Cancer Proteomics and Molecular Heterogeneity 04/25/2013 OBSERVATIONAL unchanged 4,871.85 0 Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry 04/30/2013 OBSERVATIONAL unchanged 4,866.85 0 Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. 05/03/2013 INTERVENTIONAL unchanged 4,863.85 0 Ovarian Tissue Transplantation 06/06/2013 INTERVENTIONAL unchanged 4,829.85 0 Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer 06/07/2013 INTERVENTIONAL unchanged 4,828.85 0 Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery 06/07/2013 INTERVENTIONAL unchanged 4,828.85 0 Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy 06/11/2013 INTERVENTIONAL unchanged 4,824.85 0 An Optimized Programming of Healthy Children (APPROACH) 07/10/2013 INTERVENTIONAL unchanged 4,795.85 0 Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer 07/23/2013 INTERVENTIONAL unchanged 4,782.85 0 Prophylactic Salpingectomy With Delayed Oophorectomy 07/25/2013 INTERVENTIONAL unchanged 4,780.85 0 Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer 08/05/2013 INTERVENTIONAL unchanged 4,769.85 0 Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer 08/26/2013 INTERVENTIONAL unchanged 4,748.85 0 Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer 09/17/2013 INTERVENTIONAL unchanged 4,726.85 0 Endometriosis, Food Consumption and Fertility 09/20/2013 OBSERVATIONAL unchanged 4,723.85 0 Assessment of Paclitaxel-Induced Neuropathy 09/30/2013 OBSERVATIONAL unchanged 4,713.85 0 Muscle Fiber Fragment Treatment for Urinary Incontinence 09/30/2013 INTERVENTIONAL unchanged 4,713.85 0 Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery 10/01/2013 INTERVENTIONAL unchanged 4,712.85 0 SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy 10/22/2013 OBSERVATIONAL unchanged 4,691.85 0 Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer 10/28/2013 INTERVENTIONAL unchanged 4,685.85 0 A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction 11/05/2013 INTERVENTIONAL unchanged 4,677.85 0 Predictive Clinical and Biological Parameters in Gynecological Cancer 11/06/2013 INTERVENTIONAL unchanged 4,676.85 0 REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy 11/14/2013 INTERVENTIONAL unchanged 4,668.85 0 Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC) 11/25/2013 OBSERVATIONAL unchanged 4,657.85 0 Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer 11/25/2013 INTERVENTIONAL unchanged 4,657.85 0 Chronic Toxicities Related to Treatment in Patients With Localized Cancer 11/25/2013 INTERVENTIONAL unchanged 4,657.85 0 FDG PET/CT in Breast Cancer Bone Mets 11/27/2013 OBSERVATIONAL unchanged 4,655.85 0 Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine 12/09/2013 INTERVENTIONAL unchanged 4,643.85 0 Characterization of a Prospective Cohort of Women With PCOS 12/13/2013 OBSERVATIONAL unchanged 4,639.85 0 Group Versus Individual Physiotherapy for Urinary Incontinence in Aging Women 01/20/2014 INTERVENTIONAL unchanged 4,601.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology